Curtis Ruegg, EVP, Technical Operations at Revance Therapeutics, Inc. (RVNC), sold 2,000 shares at $22.24 ($44K) on 2015-04-17, disclosed to the SEC on 2015-04-21.
Scheduled sale ($44k) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.23 | 1,000 | $22K | 50.0% |
| 2 | $22.24 | 1,000 | $22K | 50.0% |
| Total | $22.23 avg | 2,000 | $44K | 100% |
| Filing → |
| RVNC | SELL | 2016-04-13 | $19K | — | Filing → |
| RVNC | SELL | 2016-03-09 | $20K | — | Filing → |
| RVNC | SELL | 2016-02-10 | $18K | — | Filing → |